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The type I collagenopathies are a group of heterogeneous connec-
tive tissue disorders, that are caused by mutations in the genes
encoding type I collagen and include specific forms of osteogenesis
imperfecta (OI) and the Ehlers–Danlos syndrome (EDS). These disor-
ders present with a broad disease spectrum and large clinical vari-
ability of which the underlying genetic basis is still poorly
understood. In this study, we systematically analyzed skeletal phe-
notypes in a large set of zebrafish, with diverse mutations in the
genes encoding type I collagen, representing different genetic forms
of human OI, and a zebrafish model resembling human EDS, which
harbors a number of soft connective tissues defects, typical of EDS.
Furthermore, we provide insight into how zebrafish and human
type I collagen are compositionally and functionally related, which
is relevant in the interpretation of human type I collagen-related
disease models. Our studies reveal a high degree of intergenotype
variability in phenotypic expressivity that closely correlates with
associated OI severity. Furthermore, we demonstrate the potential
for select mutations to give rise to phenotypic variability, mirroring
the clinical variability associated with human disease pathology.
Therefore, our work suggests the future potential for zebrafish to
aid in identifying unknown genetic modifiers and mechanisms un-
derlying the phenotypic variability in OI and related disorders. This
will improve diagnostic strategies and enable the discovery of new
targetable pathways for pharmacological intervention.
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Collagens are a large family of diverse, structural extracellularmatrix proteins, among which fibril-forming molecules
dominate. Type I collagen is the most abundant fibrillar collagen
in vertebrates, encoded by two genes, the COL1A1 and the COL1A2
genes that express the α1(I) and α2(I) chain, respectively. In the
endoplasmic reticulum, after extensive posttranslational modifi-
cation of proline and lysine residues, two associated proα1(I)
chains and one proα2(I) chain fold into a left-handed triple-helical
linear molecule. The characteristic repetitive Gly-X-Y triplet se-
quence of the helical domain (X frequently proline, and Y fre-
quently hydroxyproline) produces a tightly intertwined trimeric
conformation (1). During the secretion of the native procollagen
molecules into the structural extracellular matrix and assembly
into fibrils, first the carboxypropeptides and then the amino-
propeptides are removed by propeptidases.
Genetic mutations in the type I collagen-encoding genes are
associated with a group of rare and heterogeneous disorders, the
type I collagenopathies, which encompass specific forms of
osteogenesis imperfecta (OI), the Ehlers–Danlos syndrome (EDS),
and Caffey disease (2). Caffey disease, or infantile cortical hy-
perostosis, is a rare condition caused by a specific Arg to Cys
substitution (p.R836C) in the α1(I) chain of type I collagen and
is characterized by an inflammatory process with swelling of soft
tissues and periosteal hyperostosis of some bones (2). OI, which
is a disorder characterized by a low bone mass and a high bone
fragility in human patients, is predominantly caused by dominant
mutations in COL1A1 or COL1A2 (3). According to the original
classification by Sillence et al. (4), these COL1A mutations un-
derlie the classic subtypes of OI (types I–IV), which at a bio-
chemical level are effected by either quantitative or qualitative
defects in type I collagen fibrils. OI type I, the mildest form of
the disease, generally arises due to mutations that cause a pre-
mature stop codon in COL1A1, creating a functional null allele,
so that only half of the normal amount of type I collagen is
synthesized (5). The presence of one COL1A2-null allele is not
associated with a disorder, while a complete loss of COL1A2
causes the cardiac valvular subtype of EDS, which is associated
with variable joint hypermobility and skin fragility, and early-
onset severe cardiac valvular problems, rather than bone fragil-
ity (6). In the more severe phenotypes of classic OI (OI types II,
III, and IV), type I collagen exhibits a structural defect. The
great majority of causative mutations in these types are single
nucleotide changes, giving rise to the substitution of a Glycine
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residue for a bulky, polar, or charged amino acid, disrupting the
highly conserved Gly-X-Y triplet sequence. Following the Sillence
et al. (4) classification, type IV is described as being moderate,
type III as severe or progressively deforming, and type II as causing
perinatal lethality. Besides the classic types of OI, mutations in
noncollagenous genes have been reported to mostly cause auto-
somal recessive forms of OI. These genes generally encode for
proteins that interact with type I collagen, acting as key players in
processes such as collagen synthesis, collagen folding and post-
translational modification, intracellular trafficking of collagen, or
collagen fibril cross-linking (5).
Inherent to the pathology of OI is a large clinical variability,
with phenotypes ranging from nearly asymptomatic with a mild
predisposition to fractures and a normal lifespan, to forms as-
sociated with multiple fractures and severe deformities already
present in utero that may cause perinatal lethality (7). In the
classic dominant forms of OI types II–IV, some general princi-
ples have emerged for genotype–phenotype correlations (3, 8).
Mutations in COL1A1 are generally associated with a more se-
vere phenotype than mutations in COL1A2. Furthermore, the
position of mutations along the α-chains can modulate the out-
come. Nevertheless, numerous exceptions to these guidelines
have already been demonstrated (9). Of note, extensive pheno-
typic variability resulting from identical mutations has been de-
scribed in recent years to be common in both dominant and
recessive forms of OI (10–12). This renders prediction on the
clinical outcome of certain mutations in OI particularly challeng-
ing. Dissecting the underlying basis of this phenotypic variability is
crucial to enable a more profound understanding of molecular
mechanisms in OI, to enable the discovery of new targetable
pathways for intervention, and to identify novel biomarkers for
diagnostics and monitoring of pharmacological treatments.
To study human skeletal dysplasias, zebrafish (Danio rerio)
models are increasingly being used as a valuable complementa-
tion or predecessors to the traditional murine models (13, 14).
Besides their unique attributes, such as the rapid development,
large offspring numbers, and ease and speed in generating mu-
tant lines, zebrafish bone mutants tend to survive into adulthood
far more easily than corresponding mouse models, making them
also available for the study of later stages of skeletal develop-
ment and maturation (13, 15). Furthermore, due to the high
conservation of developmental programs in osteogenesis be-
tween teleosts and mammals, functional gene and pathway
analysis in zebrafish can yield relevant insights into human bone
disease (16). Detailed reports have already documented simi-
larities and differences between teleost and mammalian bone
biology that are relevant for modeling human bone disease (13,
14, 17, 18). One of these differences is the composition of type I
collagen in zebrafish, which harbors not one but two orthologs of
the human COL1A1 gene, namely col1a1a and col1a1b, encoding
the α1- and α3-chain, respectively. Although some characteristics
of zebrafish type I collagen have already been addressed (19),
more insight into the functional implications of this additional
teleost-specific α-chain is needed.
In recent years, different zebrafish mutants have already been
reported to accurately model certain genetic types of human OI
(20–23). However, these studies were focused on a detailed
analysis of single mutants, modeling certain subtypes of OI, while
the greatest strength of the zebrafish lies in the ease of accom-
modating the parallel analysis of multiple mutant models.
Moreover, recent advances in μCT-based methods enable de-
tailed and rapid skeletal phenotyping of zebrafish mutants, which
often have been resistant to such methodologies (24). Advances
in processing and analysis have now allowed analysis of hundreds
of morphological and densitometric traits in large sets of
zebrafish skeletal mutants (25). In this work, we applied sys-
tematic collagen analysis with skeletal phenomics to characterize
a large set of zebrafish with mutations in type I collagen genes, as
seen in patients with different forms of classical OI and EDS, to
assess to which extent key features of human type I collageno-
pathies are recapitulated.
Results
Zebrafish with Different Mutations in Type I Collagen Show Variable
Skeletal Phenotypes. We systematically analyzed skeletal pheno-
types in a large set of zebrafish models carrying different mu-
tations in the zebrafish type I collagen-encoding genes col1a1a,
col1a1b, and col1a2 (Table 1). As a reference, we also included
two knockout mutants, bmp1a−/− and plod2−/−, representing se-
vere recessive forms of OI with defects in type I collagen pro-
cessing and cross-linking, respectively (22). Upon μCT scanning,
we observed a large diversity of skeletal phenotypes throughout
the whole set of mutants. Severe morphological abnormalities
included callus formation, bowing and kinking of the ribs, mal-
formation of the vertebral column, short stature, and craniofacial
abnormalities (Fig. 1, Table 2, and SI Appendix, Fig. S1), in-
dicating compromised bone quality. Next, we performed μCT-
based phenomic profiling (25) (SI Appendix, Fig. S2) to quantify
200 different descriptors of bone morphology and mineralization
in the axial skeleton of each animal. Specifically, we segmented
each of 20 vertebrae into three skeletal elements—the neural
arch (Neur), centrum (Cent), and haemal arch/ribs (Haem)—
and for each skeletal element, we computed four primary pa-
rameters: tissue mineral density (TMD, mgHA/cm3), volume
(Vol, μm3), and thickness (Th, μm), and also centrum length
(Cent.Le, μm). In total, we analyzed 28,000 phenotypic data
points derived from 140 different animals. To explore inter-
genotype variability for each trait, means were calculated within
each genotype (mutant and control) and normalized to the SD
of their respective control population [z-score = (mean value
mutant − mean value control)/SD control]. In general, we ob-
served a large diversity of skeletal phenotypes throughout the
whole set of mutants (Fig. 2). We found that phenotypic severity
(as measured by the absolute value of the z-score) tended to be
highest for mutants associated with collagen processing (plod2,
bmp1a) and qualitative collagen defects (e.g., col1a1achi/+,
col1a2dmh15/+, col1a1bdm29/+), and lower for mutants associated
with quantitative collagen defects (e.g., col1a1a+/−, col1a1b−/−,
col1a2−/−). Remarkably, some mutants with qualitative defects
(and collagen processing defects) exhibited a pronounced en-
richment of positive z-scores for some traits (e.g., Cent. TMD).
We interpret the different degrees of phenotypic severity in
mutants associated with qualitative or quantitative collagen de-
fect, as well as the variability in direction of effect (i.e., positive
or negative effect on bone mass or mineralization) across gen-
otypes, to reflect the clinical variability observed in human type
I collagenopathies.
Heterozygous Loss of both α1(I) and α3(I) in Zebrafish Is Reminiscent
of Mild OI Type I. Human patients with a heterozygous COL1A1-
null allele (COL1A1 haploinsufficiency) develop OI type I,
characterized by short or normal stature, mild bone fragility,
relatively few fractures, and minimal limb deformities. In
zebrafish two orthologs of the human COL1A1 exist, namely
col1a1a encoding α1(I) and col1a1b encoding α3(I). Two
zebrafish knockout mutants with a premature stop-codon mu-
tation in either col1a1a or col1a1b show absence of α1(I) and
α3(I), respectively, in the vertebral bone (Fig. 3A and SI Ap-
pendix, Fig. S3). However, both qualitative and quantitative as-
sessment of μCT scans of the vertebral column of heterozygous
col1a1a+/− or col1a1b+/− zebrafish mutants revealed no skeletal
abnormalities (Fig. 1 and SI Appendix, Figs. S4 and S5), which is
most likely related to functional redundancy between both
paralogs. Hence, we generated a double-heterozygous knockout
mutant (col1a1a+/−;col1a1b+/−), which displays a mild skeletal
phenotype, with a low frequency of spontaneous fractures (calluses
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in the ribs), scoliosis and localized compression, fusions, and
mild malformation of the vertebral bodies in some of the mutant
fish (Figs. 1 and 4A and Table 2). Quantitative measures of bone
in this mutant revealed localized reduction of centrum volume,
length, and TMD (SI Appendix, Fig. S6). However, these results
were not found to be statistically significant throughout the entire
Fig. 1. μCT images of different zebrafish models with affected type I collagen. For μCT scanning, we included several mutants with a nonsense or splice
mutation in col1a1a, col1a1b, or col1a2, generating a knockout of these genes (col1a1a−/− not viable). These mutants are grouped together and indicated as
“type I collagen knockout (KO) alleles—quantitative defect” (shown in orange). Another set of mutants carries mutations resulting in substitutions [indicated
as “type I collagen amino acid (AA) substitutions—qualitative defect, shown in blue] of a Gly residue in α1(I) (col1a1admh13/+, col1a1admh14/+ and col1a1achi/+),
α2(I) (col1a2dmh15/+), or α3(I) (col1a1bdmh29/+). The microwaved (col1a1amed/med) mutant carries a homozygous Glu substitution in α1(I). Finally, we included
two mutant models with a knockout mutation in the bmp1a and plod2 genes (“KO alleles in genes involved in type I collagen processing,” shown in green).
Representative fish from each mutant genotype are shown. Callus formation in ribs (arrowheads), local compressions of the vertebral column (brackets), and
kyphosis (arrow), are indicated (also listed in Table 2).
Table 1. List of mutant zebrafish alleles analyzed in this study
Gene Allele Effect on protein level
Effect on homologous
human protein
Type I collagen knockout alleles (quantitative defect)
col1a1a sa1748 p.(Gly1179X)
col1a1b sa12931 p.(Cys68X)
col1a2 sa17981 p.(Ala154Cysfs*23)
Type I collagen amino acid substitutions (qualitative defect)
col1a1a chihuahua (chi) p.(Gly736Asp) α1(I) p.(Gly574Asp)
col1a1a microwaved (med) p.(Glu888Lys) α1(I) p.(Glu726Arg)
col1a1a dmh13 p.(Gly1093Arg) α1(I) p.(Gly931Arg)
col1a1a dmh14 p.(Gly1144Glu) α1(I) p.(Gly981Glu)
col1a1b dmh29 p.(Gly1123Asp) α1(I) p.(Gly958Asp)
col1a2 dmh15 p.(Gly882Asp) α2(I) p.(Gly802Asp)
Knockout alleles in genes involved in Type I collagen processing
bmp1a sa2416 p.(Arg522X)
plod2 sa1768 p.(Tyr679X)
Mutant alleles are listed, along with the effect of the mutation on protein level (p-notation). For alleles
causing an amino acid substitution, the corresponding effect on the homologous human protein is listed in
the p-notation (35).
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length of the vertebral column, most likely due to the intragenotype
phenotypic variability and incomplete penetrance, which is fur-
ther demonstrated by the much larger spread of values for the
different skeletal parameters in the group of mutant fish compared
with control fish (Fig. 4B).
A Complete Loss of Zebrafish α1(I), but Not α3(I), Causes Lethality in
Early Larval Stages. We next assessed the effect of a complete
(homozygous) loss of α1(I) or α3(I) on survival and on skeletal
integrity. In progeny resulting from an in-cross of col1a1a+/−;
col1a1b+/− mutant fish, all possible genotypes were shown to be
present at 7 d postfertilization (dpf), while from 15 dpf on some
genotypes were underrepresented according to Mendelian pre-
dictions, or even lost (Fig. 5A). Eventually, all genotypes con-
taining a homozygous knockout of col1a1a [loss of α1(I)] were
found to be lethal by the age of 3 mo. Homozygous mutant
col1a1b−/− mutants [loss of α3(I)] were present by the age of
3 mo, however at reduced numbers if combined with heterozy-
gous loss of col1a1a (col1a1a+/−;col1a1b−/−). Fish with a com-
plete loss of α3(I), but intact α1(I) did not show significant
alterations of bone morphology (SI Appendix, Fig. S7), although
some fish showed evidence of fractures (Fig. 1 and Table 2) and
increased TMD throughout the vertebral column, indicating an
impaired bone quality.
Because the knockout of col1a1a compromises viability from
7 dpf on, the general morphology of col1a1a−/− mutant larvae
was assessed at this stage. These larvae lacked the presence of an
inflated swim bladder, a structure that is essential for survival
once larvae are required to actively feed (Fig. 5B). Furthermore,
the distal margins of the pectoral fins, and the finfold, were
shown to be ruffled in these mutants (Fig. 5 B and C). These fin
structures are structurally supported by fin actinotrichia, which
are prefin-ray structures composed of collagen fibers (26). Upon
detailed examination of the finfold, these actinotrichia were
found to be absent in col1a1a−/− mutant larvae (Fig. 5D). This is
in concordance with earlier studies reporting these structures to
only contain type I collagen as α1(I) homotrimers (26, 27), while
in other tissues both α1(I) and α3(I) are present (26, 28).
Complete Loss of α2(I) in Zebrafish Leads to Soft Connective Tissues
Abnormalities, Reminiscent of the Human EDS. We studied a
zebrafish mutant with a splice mutation in col1a2, resulting in the
absence of α2(I) (Fig. 3B). In humans, heterozygosity for
COL1A2-null mutations (COL1A2 haploinsufficiency) is not
known to be pathogenic, while a complete absence of α2(I)
chains is associated with the cardiac valvular type of EDS, a
connective tissue disorder characterized by skin fragility, joint
hypermobility, early-onset, severe and progressive cardiac valvular
defects, and mild osteopenia with increased risk of fractures in some
patients (6, 29). Similarly, zebrafish with a heterozygous col1a2
knockout are asymptomatic (Fig. 6A and SI Appendix, Fig. S8),
while homozygous col1a2 knockouts were severely affected with
marked kyphosis of the vertebral column at the level of transitioning
precaudal to caudal vertebrae (Figs. 1 and 6A, arrowhead). FishCuT
analysis demonstrated a slightly lower mineralization in the verte-
bral column of col1a2−/− mutant fish, although this was found not
to be significant throughout the whole vertebral column (SI Ap-
pendix, Fig. S9). No rib fracture calluses were observed (Table 2).
Histological analysis showed local alterations in bone thickness,
fusions at some of the vertebral endplates, and loss of typical
Sharpey fibers (Fig. 6D).
Table 2. Phenotypical features observed upon μCT-scanning of adult mutant fish included in this study
Zebrafish mutant
Associated human
disorder + unique
clinical features
No. of
animals
with rib
fracture
callus
No. of
animals
with
vertebral
fusions
VC
over/undermineralized
(TMD, P < 0.05)
Kyphosis
(K) and/or
scoliosis (S)
Decreased
bodylength–SL
(P < 0.0001)
Type I collagen knockout alleles (quantitative defect)
col1a1a+/− OI type I, Mild. Normal
or short stature, little
or no deformities
0/5 0/5 / / /
col1a1b+/− 0/5 0/5 / / /
col1a1a+/−;col1a1b+/− 1/5 2/5 / S /
col1a1b−/− 2/5 0/5 / / /
col1a2+/− No disease 0/5 0/5 / / /
col1a2−/− EDS, cardiac valvular
type
0/5 0/5 / K Y
Type I collagen amino acid substitutions (qualitative defect)
col1a1achi/+ OI types II–IV, moderate
to severe/lethal.
Short stature and
bone deformities.
Overmineralization
(36)
5/5 5/5 / K + S Y
col1a1amed/med 1/6 0/6 Undermineralized S /
col1a1admh13/+ 1/6 4/6 / S Y
col1a1admh14/+ 0/5 1/5 / S Y
col1a1bdmh29/+ 5/6 6/6 Overmineralized K + S Y
col1a2dmh15/+ 6/6 6/6 Overmineralized K + S Y
Knockout alleles in genes involved in type I collagen processing
bmp1a−/− OI type XIII, severe.
Marked
overmineralization
0/5 0/5 Overmineralized K + S Y
plod2−/− Overlap BS–OI
moderate/severe
5/5 5/5 Overmineralized K + S Y
For each mutant model, the specific disorder and unique clinical features associated with a similar mutation in human patients is listed (7, 20). In addition,
per genotype the ratio (no.) of animals that had at least one rib fracture callus (third column, never observed in any wild-type control animals), or fusion of
vertebral bodies in the vertebral column (fourth column, only rarely detected in wild-type control animals) are given. TMD in the VC was quantified in FishCuT
software and was indicated as “undermineralized” if significantly decreased or as “overmineralized” if significantly increased according to the global test (P <
0.005). The presence of kyphosis (K) and or scoliosis (S) was also evaluated on 3D-scan images. Finally, the presence of a significant decrease (P < 0.001) in the
mean body length, [i.e., the standard length (SL, measured from the tip of the snout to basis of the caudal fin) of mutant genotypes is indicated] (see SI
Appendix, Fig. S20 for boxplots of SL measurements per genotype, compared with their wild-type siblings). Other abbreviations: BS, Bruck syndrome; VC,
vertebral column.
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Given the joint involvement in human patients with a com-
plete loss of α2(I) (6), we explored the presence of similar de-
fects in col1a2−/− mutant fish. Histological analysis of the
intervertebral ligament (IVL) showed a normal elastin layer, but
reduced notochord sheath layer and a complete loss of type I
collagen fibrous ligament, causing local distortion and disloca-
tion of the IVL and intervertebral space in some parts of the
vertebral column (Fig. 6D), which most likely underlies the ky-
phosis identified in this mutant and resembling the joint dislo-
cations seen in human patients (6, 30, 31). The skin of col1a2−/−
mutant fish was also more fragile and easily damaged, compared
with the skin of wild-type control fish. Histological analysis of
adult skin showed that the dermis, which is composed of two
collagen fibril layers in zebrafish, is half the thickness in mutant
fish compared with dermis of wild-type siblings (Fig. 6B). Bio-
mechanical load-to-failure strength of soft connective tissues was
analyzed by determining the ultimate tensile strength of tissue
specimens from five col1a2−/− mutant and five control fish (Fig.
6C). Tissues lacking α2(I) ruptured at a significantly lower peak
load (0.027 ± 0.0079 N), compared with tissue samples from wild-
type siblings (0.081 ± 0.011 N, P < 0.0001), indicating significantly
diminished strength of soft connective tissue in col1a2−/− mu-
tant fish. Histological sections of the adult zebrafish heart from
col1a2−/− mutants showed normal morphological appearances of
the cardiac valves and col1a2−/− larvae displayed normal cardiac
function and blood flow (SI Appendix, Fig. S10).
Genotype/Phenotype Relations in Mutants with Impaired Quality of
Type I Collagen. We next studied the skeleton of a set of mutants
carrying a point mutation in either of the type I collagen-
encoding genes, leading to impaired type I collagen quality (Fig.
1, Table 1, and SI Appendix, Figs. S11–S17). In human patients
these types of mutations lead to OI types II–IV, which have
moderate to severe or even lethal phenotypes with short stature,
bone deformities, and hypermineralized bone (32, 33).
The col1a2dmh15/+ mutant represents the most detrimental
phenotype of all analyzed mutants (Fig. 1 and SI Appendix, Fig.
S16), with heavily distorted, misshapen, and overmineralized
axial and cranial skeletons. This is in concordance with hu-
man data because Gly substitutions in the homologous region
of α2(I) are associated with lethal OI in human patients due
to the presence of severe skeletal malformations early in fetal
Fig. 2. Inter- and intragenotype phenotypic variability demonstrated by quantitative μCT analysis in FishCuT. For a set of parameters that quantify mor-
phology and mineralization in the vertebral column of the different mutant populations, z-scores are given for each mutant genotype [z-score = (mean value
mutant − mean value control)/SD control]. On the y axis, mutants associated with a collagen processing defect are indicated in green, mutants with a
qualitative defect in type I collagen are indicated in dark blue, and mutants with a quantitative defect in type I collagen are indicated in orange. Blue bars
indicate values that were statistically significantly altered for that mutant genotype, compared with its control as analyzed by the global test (see SI Appendix,
Figs. S4–S19). Note the large variability in the effect of each mutation on the different parameters.
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development, in addition to other extraskeletal anomalies (Fig. 7)
(34). The col1a1achi/+ mutant, reported earlier (21, 35), carries
the same mutation that was identified in a human patient with
severe and heavily deforming OI type III (34), and also displays a
moderate to severe phenotype with skeletal malformation, in-
cluding shorter vertebral bodies, kyphoscoliosis, and evidence of
fractures (Fig. 1, Table 2, and SI Appendix, Fig. S13). The alleles
dmh13, dmh14, and dmh29 all cluster in the major ligand binding
region 3 of type I collagen (Fig. 7), and while this region repre-
sents a hotspot for ligand interactions, mutations in this region are
associated with variable phenotypic outcomes, ranging from
moderate OI type IV to perinatal lethality (OI type II) (3, 34).
This variability of phenotypic severity was also observed upon
comparing the three different zebrafish mutants, with col1a1bdmh29/+
fish displaying the most severe skeletal phenotype with kyphosco-
liosis and shorter, thicker, and overmineralized vertebral bodies and
frequent rib fractures (Fig. 1, Table 2, and SI Appendix, Figs. S14,
S15, and S17). The col1a1a med allele, reported earlier by Asharani
et al. (20), was shown to have no effect in heterozygous state but
caused pronounced effects on TMD, volume, and thickness of the
vertebral bodies when present in homozygous state (SI Appendix,
Figs. S11 and S12). However, as no comparable mutations have
been identified in human patients, this col1a1amed/med mutant is
likely less relevant for human OI.
To detect the presence of collagen overmodification, which is
typically caused by collagen I glycine substitutions in human OI
patients, collagen from adult bone was extracted by heat de-
naturation and subjected to SDS/PAGE. While migration of the
α-chains was not affected in bone from col1a2dmh15/+, col1a1bdmh29/+,
and col1a1amed/med mutants, retarded α-chain mobility, indicat-
ing collagen overmodification, was observed for col1a1achi/+,
col1a1admh13/+, and col1a1admh14/+ mutants (Fig. 8).
Discussion
In this work, we present a skeletal phenomic analysis of a set of
zebrafish with mutations in type I collagen that model different
Fig. 3. SDS/PAGE and mass-spectrometry analysis of bone collagen from adult spine of col1a1a, col1a1b, and col1a2 mutant fish with a quantitative type I
collagen defect. (A) SDS/PAGE analysis of bone collagen extracted from individual adult spines of control fish, col1a1b+/−, col1a1b−/−, col1a1a+/−, and col1a1a+/−;
col1a1b+/−mutant fish. For each genotype, three biological replicates were taken into account. Following SDS/PAGE separation, an in-gel trypsin digest of the α1
(I) + α3(I) bands of each sample was performed and mass-spectrometry analysis was used to determine the relative amount of α1(I) and α3(I) in each sample. The
expected α3(I)/α1(I) ratios (red lines in diagram) were approximated in samples from individual mutants (blue bars), illustrating that the reported nonsense
mutations in col1a1a and col1a1b result in loss of the α1(I) chain and the α3(I) chain, respectively. Accordingly, in col1a1b−/−mutants, no tryptic peptides of α3(I)
could be detected, confirming decay of mutant col1a1b mRNA transcripts. (B) SDS/PAGE analysis of bone collagen extracted from individual adult spines of
col1a2+/− and col1a2−/− mutant fish and control siblings. For each genotype, three biological replicates were taken into account. Col1a2−/− mutant fish show a
complete absence of col1a2 encoded α2(I) (red arrowhead). Note also the absence of the β1,2 dimers (black arrowhead) in col1a2−/− mutant fish.
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type I collagenopathies, including the classic types of OI and a
specific subtype of EDS. By systematically analyzing the skeletal
phenotypes in this set of mutants, we illustrate the high ability of
zebrafish mutants to reproduce the genetic and phenotypic fea-
tures of type I collagenopathies.
OI in human patients is characterized by bone fragility, leading
to a higher susceptibility to fractures, and in addition, misshapen
bones and skeletal malformation can be observed (7). The
presence of these disease features and the extent to which they
manifest is largely associated with the specific subtype of OI (7).
As such, quantitative defects in type I collagen, underlying OI
type I, tend to cause mild skeletal defects in human patients with an
increased susceptibility to fractures but minimal bone deformity.
Zebrafish mutants with similar quantitative type I collagen
Fig. 4. col1a1a+/−;col1a1b+/− mutant fish exhibit intragroup variability in
phenotypic expressivity. (A) Different col1a1a+/−;col1a1b+/− mutant siblings
were analyzed using μCT scanning at 5 mo of age (mutant 1 to mutant 5).
Upon comparison of the different mutant siblings, both incomplete pene-
trance and a variable expressivity of features indicative of compromised bone
quality was observed, which include fractures (arrowheads) and local com-
pressions in the vertebral column causing a distorted shape of the vertebral
bodies (brackets). (B) Intragroup variability for col1a1a+/−;col1a1b+/− mutant
fish is demonstrated for volume and TMD of the vertebral centra, with values
in the mutant group showing a much larger spread than compared with the
control group. The different colors in one graph represent different individual
fish of the same group (mutant siblings or control siblings).
Fig. 5. In-depth analysis of mutants with partial or complete loss of col1a1a
and/or col1a1b. (A) Segregation analysis of the different mutant genotypes
generated from an in-cross of col1a1a+/−;col1a1b+/− double-heterozygous
mutant fish. Progeny were genotyped at three different time points
(100 fish per time point): 7 dpf, 15 dpf, and adult stage (3 mo). The relative
abundance of each genotype is given for each time point as a percentage.
“Expected” indicates the theoretical abundance of each genotype, follow-
ing Mendelian segregation. All combinations with a complete loss of col1a1a
(col1a1a−/−, indicated in red shades), are less viable and completely lost
when progeny reached adulthood. Genotypes that contain a complete loss
of col1a1b (col1a1b−/−, indicated in green shades) are still present at adult
stage. Black indicates the parental genotype, white indicates wild-type fish,
and gray represents the other remaining genotypes. (B) Phenotype of
col1a1a−/− mutant larvae at 7 dpf, compared with wild-type siblings.
Col1a1a−/− mutant larvae present with a noninflated swimbladder (asterisk)
and a ruffled finfold (arrowhead). (C) Ventral view and detail of the pectoral
fins showing frilly distal margins (arrowhead) in the pectoral fins of
col1a1a−/− mutant larvae at 7 dpf. (D) Detail of the col1a1a−/− mutant larvae
finfold at 7 dpf, showing an absence of fin actinotrichia fibers, which can be
clearly observed in the finfold of wild-type siblings (arrow).
Gistelinck et al. PNAS | vol. 115 | no. 34 | E8043
M
ED
IC
A
L
SC
IE
N
CE
S
defects (col1a1a+/−;col1a1b+/− mutants) also presented with in-
creased fracture risk, apparent from the presence of spontaneous
fractures in the ribs, while skeletal deformities were minimal with
only localized and mild compressions of the vertebral column in
some of the mutant fish. Conversely, qualitative type I collagen
defects in zebrafish evoked a more pronounced effect on the
skeleton, with frequent fractures, kyphoscoliosis and malforma-
tion of the vertebral bodies, and misshapen ribs and fin bones.
These phenotypes correspond to the moderately severe, pro-
gressive deforming or lethal clinical phenotypes of OI types II–
IV. Importantly, the more severely affected mutants of this
group (dmh15 and dmh29) also displayed overmineralization in
the vertebral column, a feature often seen in human OI, and
especially associated with the more severe cases in human pa-
tients (32, 33). Additionally, biochemical analysis argued for type
I collagen overmodification, one of the typical features in human
OI, in some of the mutants with a qualitative defect. Moreover,
the variability of the excessive posttranslational modification
throughout this set of mutants corresponds to the situation in
human patients with OI types II–IV, where variable collagen
overmodification has been related to the position of the muta-
tion in the type I collagen helix (34, 36). Overall, the genotype–
phenotype analysis we performed shows the validity of the in-
cluded zebrafish mutants as models for different forms of
human OI.
A hallmark feature of OI in humans is the large clinical
spectrum of phenotypes, with disease presentation that can differ
from very mild to perinatal lethal, even with the same causative
mutation. The underlying molecular basis of this variability re-
mains largely not understood. The zebrafish mutants described
here similarly show significant variation in their expressivity.
Intragenotype variability is illustrated in col1a1a+/−;col1a1b+/−
mutant siblings, as some show fractured ribs or vertebral com-
pressions, while others do not. In addition, there is a large var-
iability in vertebral morphology and mineralization in mutant
siblings, in contrast to control siblings. A likely explanation for
Fig. 6. In-depth analysis of col1a2+/− and col1a2−/−
mutant fish. (A) Visual phenotype of col1a2 mutant
and wild-type siblings. Both col1a2+/+ control, and
col1a2+/− mutant fish display a normal morphology,
while col1a2−/− mutant are dysmorphic and display
kyphosis (arrowhead). The typical stripe pattern in
the skin is disturbed in col1a2−/− mutant fish, but
normal in col1a2+/+ controls and col1a2+/− mutant
fish. (B) Masson’s Trichrome staining of histological
sections of the skin of an adult col1a2−/− mutant fish
and a col1a2+/+ control sibling. Note the much
thinner dermis (asterisk), composed of layers of col-
lagen fibrils (stained blue) in col1a2−/− mutant fish
compared with col1a2+/+ controls. (C) Average
maximum tensile strength, measured by bio-
mechanical testing of skin flaps dissected from five
adult col1a2−/− mutant fish and five col1a2+/+ con-
trol fish, illustrating strongly decreased strength of
soft connective tissues in mutant fish (P < 0.0001).
(D) Histological analysis of the vertebral column of
adult fish, sagittal sections stained with H&E. Shown
at the Left are two adjoining vertebral body end-
plates (Vep, i.e., the region where two adjacent
vertebral bodies meet and are connected by the IVL)
in a col1a2+/+ control and a col1a2−/− mutant adult
fish. The black rectangles indicate the region which
is shown at a higher magnification in the image next
to it on the Right, depicting the IVL in detail. In
control fish, the IVL is typically composed of three
distinct layers or tissues: the notochord sheet (Ns,
mainly type II collagen), the outer elastin layer (OEL),
and a layer of type I collagen fiber bundles (cI). In the
col1a2−/− mutants, IVL composition is abnormal: the
OEL was still present, the Ns layer could be observed
but was extremely reduced, but no layer of type I
collagen fibers (cI) could be observed. Col1a2−/−
mutant bone (B) in the vertebral bodies near the Vep
showed a loss of typical Sharpey fibers (Sf), while the
notochord cells (Nc) displayed a loss of vacuoles, in
addition to sclerosis (Sc). As shown in the two
rightmost pictures, we observed fusions of adjacent
vertebral bodies (black arrowhead) and dislocation
of the IVL and Vep (red arrow) in some of the ver-
tebrae, likely resulting in kyphosis seen in col1a2−/−
mutant fish. Other abbreviations: Ep, epidermis; Mu,
muscle fibers; Ob, osteoblasts; Scl, Scale.
E8044 | www.pnas.org/cgi/doi/10.1073/pnas.1722200115 Gistelinck et al.
the intragenotype phenotypic variability in zebrafish mutants is
the highly polymorphic nature of its genome, which closely re-
sembles human genetic variability. This makes them particularly
useful to unveil genetic determinants that can be used to map
potential regulation of phenotypic variability in humans. This is
less obvious in mouse models, where mostly inbred strains are
used for disease modeling (37, 38).
In zebrafish, type I collagen has been shown to have a different
composition than in mammals, with two orthologs of the human
COL1A1 gene, namely col1a1a and col1a1b, encoding the α1-
and α3-chain, respectively. Some insights in these differences
have already been addressed previously (19), and by studying
different knockout mutants for the type I collagen genes we
further extend this knowledge. Heterozygous loss of either α1(I)
or α3(I) did not induce any skeletal abnormalities, while reduced
levels of both α1(I) and α3(I) (col1a1a+/−;col1a1b+/− mutants)
causes a mild skeletal phenotype with increased bone fragility,
arguing for interchangeability and functional redundancy be-
tween α1(I) and the homologous α3(I). Complete loss of the
α1(I) chain causes lethality after 7 dpf, while loss of α3(I) only
shows increased early lethality if the amount of α1(I) is also di-
minished. This suggests a gene/protein dosage effect, where
α1(I) is more abundant than α3(I), as hypothesized in our pre-
vious work (19). The functional similarity between α1(I) and α3
(I) is further illustrated by the fact that glycine substitutions in
both genes can cause severe skeletal phenotypes, arguing for a
dominant-negative effect on type I bone collagen and thus in-
corporation of a substantial amount of both α1(I) and α3(I) into
the type I collagen triple helix. However, to obtain a full un-
derstanding of zebrafish type I collagen, the exact trimer stoi-
chiometry in different tissues, and the abundance of each
possible trimer composition should be examined, which is tech-
nically challenging due to the small specimen size of zebrafish
compared with the large amount of input material needed for
standard biochemical analysis techniques.
In humans, haploinsufficiency for the α2(I)-chain does not
cause a clinically significant phenotype, while complete loss of
α2(I) leads to the very rare cardiac valvular subtype of the EDS,
associated with soft connective tissue defects, including skin and
joint manifestations and propensity to cardiac valvular defects,
and relatively mild skeletal manifestations (6). These trends were
mostly recapitulated in zebrafish, as col1a2+/− mutants are asymp-
tomatic, whereas col1a2−/− mutants display an EDS-like phenotype
with different connective tissue defects; μCT-scanning showed
local vertebral abnormalities, including kyphosis, and a mild re-
duction of bone thickness and mineralization. Histological analysis
demonstrated dislocation and distortion of the fibrous connections
between some of the vertebral bodies, caused by degeneration of
the layers composing the connecting intervertebral ligament. Most
likely the latter defect is the cause of the kyphosis seen in these
mutants, with the location of the kyphosis being the area bearing
the highest mechanical force in the fish vertebral column (34).
Similar to these observations, patients with the same molecular
defect display joint dislocations but no severe skeletal involvement
(6). Interestingly, col1a2−/− mutant fish showed fragile skin upon
handling and histological analysis demonstrated a much thinner
dermis in the skin of mutant fish compared with wild-type siblings.
Consistent with these findings, bio-mechanical testing argued for a
strongly reduced strength of soft connective tissues in col1a2−/−
mutant fish. This relates to other clinical hallmark features of the
skin in human cardiac valvular EDS patients (6). Preliminary ex-
periments in col1a2−/− mutant fish could not provide any proof of
defects in cardiac morphology or functioning. However, more ex-
tensive analyses are needed to further explore a possible impaired
cardiac function in a follow-up study, focusing on an in-depth
characterization of this mutant, which was beyond the scope of
the study presented here.
Taken together, we have analyzed a large set of zebrafish
models with mutations in type I collagen that represent different
type I collagenopathies, including the classic types of OI and a
specific subtype of EDS, and illustrate the high phenotypic and
genetic similarity of these zebrafish mutants with human type I
collagenopathies. We further report a zebrafish model re-
sembling the human EDS, which harbors a number of charac-
teristic defects in the soft connective tissues. Our study surpasses
the analysis at the single-mutant model level but illustrates the
occurrence of relevant phenotypic patterns and characteristics
across a large set of genetically distinct zebrafish models. These
results, taken together with the feasibility of zebrafish for easily
accommodating large genetic and phenotypic screens, argue for
zebrafish as a promising tool in future research aiming to dissect
the underlying basis of phenotypical variability in human type I
collagenopathies, such as OI. Furthermore, we provide more
insight into the biology of zebrafish type I collagen and its con-
sequences, which are relevant in the study of any human type I
collagen related disease by using zebrafish as a model.
Material and Methods
Animals. The col1a1asa1748, col1a1bsa12931, col1a2sa17981, bmp1asa2416, and
plod2sa1768 mutant zebrafish were generated by the zebrafish mutation
project and together with wild-type AB fish obtained from the zebrafish in-
ternational resource center (ZIRC, zebrafish.org/home/guide.php) or the Eu-
ropean Zebrafish Resource center [EZRC, www.ezrc.kit.edu)] (39). The
col1a1achi were previously described (21) and the col1a1amed mutant fish were
Fig. 7. Zebrafish alleles representing amino acid substitutions in type I
collagen mapped on the helical domain of human type I collagen. The
α1 and α2 chains of the human type I collagen are schematically depicted
with the three major ligand binding regions (MLBR), indicated with red
stripped lines (34). The homologous positions to the zebrafish (ZF) alleles (as
determined by Clustal W analysis), representing mutations that cause an
amino acid (AA) substitution, are indicated with arrows. The numbering of
the zebrafish alleles indicates the total protein position of the residue.
Fig. 8. SDS/PAGE of collagen extracted from the bone of adult mutants with
qualitative type I collagen defects. SDS/PAGE analysis of acid soluble collagen
extracts from different mutant genotypes carrying amino acid substitutions in
α1(I), α2(I), or α3(I), and from matching wild-type control (ctrl) siblings (sibling
pairs indicated by brackets, in each pair the height of the α1 + α3 band in the
WT control is indicated by the red arrow) indicate that α-band migration is
markedly slower for col1a1a chi/+ and col1a1admh13/+mutants, and only slightly
decreased in col1a1admh14/+ mutants (lanes indicated by asterisks), compared
with the corresponding control. No apparent signs of collagen over-
modification could be detected for the other mutant genotypes.
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purchased from the EZRC. The col1a1admh13, col1a1admh14, col1a1bdmh29, and
col1a2dmh15 mutant fish were generated in a forward genetics screen (40). Fish
husbandry was performed as previously described (22). Studies were done in
agreement with EU Directive 2010/63/EU for animals, permit Number: ECD 17/
68. All efforts were made to minimize pain and discomfort.
μCT Scanning and Analysis. μCT-based phenotyping and quantification of
adult zebrafish was performed as previously described (25). For each geno-
type five mutants and five control fish were analyzed.
Collagen Analysis. Collagen analysis of adult zebrafish bonewas performed as
described previously (22). To determine a relative mount of α1(I)- and α3(I)-
chains, a unique tryptic peptide for each α1(1) and for α3(1) was selected and
the relative amount of the corresponding peak manually measured on the
full scan by determining peak height. For all mutant genotypes an expected
ratio of α3(I)/α1(I) was calculated based on the mean relative α3(I)/α1(I) ratio
observed in control samples and based on the assumption of absence of α3(I)
and α1(I) in the case of knockout of col1a1b and col1a1a, respectively.
Histological Analysis. Histological analysis of zebrafish tissues was performed
as described in Gistelinck et al. (22).
Bio-Mechanical Testing. Soft connective tissue sections were isolated from
5 mo old col1a2−/− mutant fish (n = 5) and wild-type control siblings (n = 5)
by decapitation and dissecting away the spine from each specimen. These
tissue specimens were kept in PBS for a maximum period of 8 h. Uniaxial
tensile tests were performed at room temperature using an Instron
5942 electromechanical test system (Instron), as previously described (41).
Detailed information regarding the procedures used is provided in SI
Appendix, Supplementary Material and Methods.
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